Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cigna Corp

Morgan Stanley Upgrades Cigna On Humira Prospects

Cigna Corp (NYSE: CI) is poised to benefit from the launch of bioequivalent Humira in July 2023, according to Morgan Stanley.

Federal regulators probe Cigna’s pharmacy benefit manager, CVS Caremark, and others. What are they investigating?

Express Scripts, the pharmacy benefit manager that Cigna Corp. bought in 2018, is being investigated by the Federal Trade Commission for what regulators claim is influence over drug prices wielded by pharmacy benefit managers and transparent business practices.

Tribune News Service

Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices

Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices

Arkansas has accused Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Sanofi SA (NASDAQ:SNY), and three of the largest pharmacy benefit managers (PBMs) of artificially driving up insulin prices. The complaint, filed by Arkansas Attorney General Leslie Rutledge, alleges the defendants devised a scheme in which the Big Pharmas would "artificially and willingly raise their…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Here's Why RBC Capital Raised Price Target On Cigna

Cigna Corp (NYSE:CI) posted 1Q22 adjusted EPS well above expectations on enterprise-wide growth, with a particularly solid performance in specialty pharmacy and better than expected MCR on lower testing and treatment costs. The company raised FY22 guidance on 1Q outperformance. The analysts raised the price target to $272 from $235, with a Sector Perform rating. …

Cigna Q1 Earnings Beat Expectations, Lifts FY22 Guidance

Cigna Corp (NYSE:CI) reports Q1 total revenues of $44.12 billion, +7.6% Y/Y, ahead of the consensus of $43.41 billion. Cigna brought in $1.18 billion in earnings, up from $1.16 billion a year ago. Q1 adjusted EPS reached $6.01 compared with $4.73 a year ago, beating the consensus of $5.18. By the end of…

Cigna Shares Fall As FY22 Guidance Falls Short Of Consensus; Q4 Profit Of $1.1B

Cigna Corp (NYSE: CI) reports

People

Leslie Rutledge

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Federal Trade Commission

CVS Health Corporation

Eli Lilly And Co

UnitedHealth Group Inc

Express Scripts

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

339,290 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play